Mr Gergawi signed the MoU on behalf of DuBiotech and Sheikh Nahyan signed on behalf of the Centre of Excellence for Applied Research and Training (CERT), the leading technology and research organisation of the United Arab Emirates (UAE).
Under the terms of DuBiotech's agreement with CERT, DuBiotech will tap into 5.7 Teraflops of supercomputing power (equivalent to 5.7 trillion mathematical operations per second) provided by the Blue Gene system at CERT. This mammoth capacity will be made available to Business Partners at DuBiotech to conduct life science research. The agreement, announced at the IBM stand at Gitex 2005, means that Business Partners engaged in biotechnology research and development at DuBiotech will have the opportunity to make use of CERT's supercomputing centre.
"This immensely powerful supercomputer is normally used in astronomy, academic and life science research involving proteomics and protein interactions requiring significant computing power. This represents a unique opportunity for DuBiotech and CERT to boost biotechnology research for the Middle East," says Dr Abdulqader Al Khayat, Executive Director of DuBiotech. "This further benefits the leaders in biotechnology who are looking to develop new advances that counter medical issues prevalent in the Gulf, such as Thalassemia, Diabetes, Anaemia and Cancer."
As well as benefiting the biotechnology sector, the announcement heralds the arrival in the region of the first such supercomputer of its kind, as this technology has been previously deployed only in Europe, the US and Asia.
"CERT intends to offer supercomputing services on demand to research institutions, colleges, universities, government and private sector companies with large data processing requirements. With the explosion of information there is a corresponding imperative to process at the Teraflop performance level offered by the Blue Gene. CERT will provide access to the only Blue Gene computer in the entire South Asia, Middle East, North Africa region." says Dr. Robert Richards, Chief Executive Officer of CERT.
In computers, FLOPS are FLoating-point Operations per Second. A Floating-point is, according to IBM, "a method of encoding real numbers within the limits of finite precision available on computers." Using floating-point encoding, extremely long numbers can be handled relatively easily. A teraflop is equivalent to a trillion computing calculations per second.
Browse
related articles
DuBiotech partners with CERT to offer super-computing on demand
- United Arab Emirates: Thursday, September 29 - 2005 at 15:04
- PRESS RELEASE
Related content
HH Sheikh Nahyan bin Mubarak Al Nahyan, UAE Minister of Education and Chairman of the Higher Colleges of Technology and HE Mohammed Al Gergawi, CEO of Dubai Holding, yesterday signed a Memorandum of Understanding (MoU) to work together to provide the Business Partners of Dubai Biotechnology and Research Park (DuBiotech), Dubai's Free Zone dedicated to the biotechnology, pharmaceutical and life sciences sectors, with the capability to conduct research using IBM's Blue Gene supercomputer.
HH Sheikh Nahyan bin Mubarak Al Nahyan and HE Mohammed Al Gergawi signing the MoU.
Article Options
Log in to request more information from DuBiotech
Posted by Anne-Birte Stensgaard, Senior News EditorThursday, September 29 - 2005 at 15:04 UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of AME Info FZ LLC / Emap Limited.
This article was updated on Wed Mar 28 2007.
Notes and Media Contacts »
For more information
Jonathan Howell-Jones
Corporate Communications Department
Dubai Technology and Media Free Zone
Tel: +971 4 391 3855
Fax: +971 4 367 2790
About DuBiotech
Announced in February 2005, the Dubai Biotechnology and Research Park (Dubiotech) is a science and business park dedicated to the biotech industry, set within a free zone infrastructure. DuBiotech has two main areas of interest. The first is the Foundation for Research & Innovation (FRI), which will be the main arm focusing on government-funded R&D. The FRI will initially focus on medical research and genetics, plant biotechnology encompassing food and agricultural biotech, environmental biotech and equine-related biotechnology. Other areas include drug discovery, stem cell research, infectious diseases and forensic research. The second arm of Dubiotech aims to set up a biotechnology industry cluster with the appropriate infrastructure, facilities and services for incubators, R&D labs, biotech-related educational institutions, suppliers, biotech-related manufacturing companies and organisations from other sectors in the industry. DuBiotech is advised by an independent steering committee on scientific, business and ethical matters. In cooperation with local and international organisations it seeks to develop comprehensive regulations for the biotech cluster.
About CERT
CERT is the commercial arm of the Higher Colleges and provides a vital link to industry for the HCT. CERT is in the business of developing and providing education, training and technology solutions for public and private sector clients. It is involved in strategic alliances with a number of large multinational organisations in developing a diverse range of business and technology solutions. CERT is estimated to be the largest private education provider in the Middle East and is positioning for an Initial Public Offering to build on its existing education and technology business. In 2005 CERT signed the largest Telematics deal in history, with IBM, to develop Telematics technology in the United Arab Emirates.
About IBM
IBM is the world's largest information technology company, with 80 years of leadership in helping businesses innovate. Drawing on resources from across IBM and key Business Partners, IBM offers a wide range of services, solutions and technologies that enable customers, large and small, to take full advantage of the new era of e-business. For more information about IBM, visit www.ibm.com
Jonathan Howell-Jones
Corporate Communications Department
Dubai Technology and Media Free Zone
Tel: +971 4 391 3855
Fax: +971 4 367 2790
About DuBiotech
Announced in February 2005, the Dubai Biotechnology and Research Park (Dubiotech) is a science and business park dedicated to the biotech industry, set within a free zone infrastructure. DuBiotech has two main areas of interest. The first is the Foundation for Research & Innovation (FRI), which will be the main arm focusing on government-funded R&D. The FRI will initially focus on medical research and genetics, plant biotechnology encompassing food and agricultural biotech, environmental biotech and equine-related biotechnology. Other areas include drug discovery, stem cell research, infectious diseases and forensic research. The second arm of Dubiotech aims to set up a biotechnology industry cluster with the appropriate infrastructure, facilities and services for incubators, R&D labs, biotech-related educational institutions, suppliers, biotech-related manufacturing companies and organisations from other sectors in the industry. DuBiotech is advised by an independent steering committee on scientific, business and ethical matters. In cooperation with local and international organisations it seeks to develop comprehensive regulations for the biotech cluster.
About CERT
CERT is the commercial arm of the Higher Colleges and provides a vital link to industry for the HCT. CERT is in the business of developing and providing education, training and technology solutions for public and private sector clients. It is involved in strategic alliances with a number of large multinational organisations in developing a diverse range of business and technology solutions. CERT is estimated to be the largest private education provider in the Middle East and is positioning for an Initial Public Offering to build on its existing education and technology business. In 2005 CERT signed the largest Telematics deal in history, with IBM, to develop Telematics technology in the United Arab Emirates.
About IBM
IBM is the world's largest information technology company, with 80 years of leadership in helping businesses innovate. Drawing on resources from across IBM and key Business Partners, IBM offers a wide range of services, solutions and technologies that enable customers, large and small, to take full advantage of the new era of e-business. For more information about IBM, visit www.ibm.com
Disclaimer »
Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com
Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.
For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions
